Logo
x

Search

Subscribe Now

Polpharma Biologics

PharmaShots Weekly Snapshots (July 11 – 15, 2022)

PharmaShots Weekly Snapshots (July 11 – 15, 2022)

  • July 15, 2022
Polpharma Biologics Report EMA's Acceptance of MAA for Biosimilar Natalizumab, a Proposed Biosimilar to Tysabr for Relapsing-Remitting Multiple Sclerosis

Polpharma Biologics Report EMA's Acceptance of MAA for Biosimilar Natalizumab, a Proposed Biosimilar to Tysabr for Relapsing-Remit...

  • July 15, 2022
PharmaShots Weekly Snapshots (October 04 - 08, 2021)

PharmaShots Weekly Snapshots (October 04 - 08, 2021)

  • October 8, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.